Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 185.716.554.985.672331-6.11
AnnualDec 175.516.255.015.5027223-5.32
AnnualDec 165.135.205.055.1327618-1.10
QuarterlyDec 161.371.441.301.3623120-4.66
QuarterlyMar 171.371.681.241.361017-1.90
QuarterlyJun 171.371.581.241.371017-5.48
QuarterlySep 171.341.541.251.31916-9.22
Long Term Growth 3.396.82-2.504.95602-16.04
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 155.425.44-0.38
QuarterlyDec 151.281.29-0.74
QuarterlyMar 161.201.172.83
QuarterlyJun 161.251.203.95
QuarterlySep 161.311.282.40
AnnualDec 145.075.07-0.01
AnnualDec 135.014.980.60
P/E Ratios
PeriodP/E Ratio
FY09.45
FY19.99
FY29.30
EPS Growth Rates
Growth RatesCompanyIndustryInd. Relative
FY1/FY0-5.38-3.070.976
FY2/FY17.4414.980.934
FY3/FY23.705.810.980
Data Provided by Thomson Reuters

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Teva. Please note that any opinions, estimates or forecasts regarding TEVA's performance made by these analysts (and therefore the Mean Estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.